Sign in
Companies / RVTY vs WAT

RVTY vs WAT: Revvity and Waters

Life Sciences Tools
Compare more companies

Revvity (RVTY) reported $2.9B in revenue against a 8.4% net margin, while Waters (WAT) reported $3.2B at a 20.3% net margin, most recently.

MetricRVTYWAT
Revenue$2.9B$3.2B
Net Income$0.2B$0.6B
Gross Margin—59.3%
Operating Margin12.5%25.4%
EPS (Diluted)$2.07$10.76
Free Cash Flow$0.5B$0.5B
Total Debt$3.2B$1.9B
P/E Ratio46.7×35.3×
P/B Ratio1.5×8.8×
Stock Price$150.88$455.05
Free: last 5 years
Fiscal yearFY2008 🔒FY2010 🔒FY2011 🔒FY2012 🔒FY2013 🔒FY2014 🔒FY2016 🔒FY2017 🔒FY2018 🔒FY2019 🔒FY2021FY2022FY2023FY2024FY2025
RVTY Revenue••••••••••••••••••••••••••••••••••••••••••••••••••$3.8B$3.8B$2.8B$2.8B$2.9B
WAT Revenue••••••••••••••••••••••••••••••••••••••••••••••••••$2.8B$3.0B$3.0B$3.0B$3.2B

More on RVTY

More on WAT

Other comparisons